Petr Pohlreich, Michal Zikan,Jana Stribrna,et al.High proportion of recurrent germLine mutations in the BRCA1gene in breast and ovarian cancer patients from the Prague area[J].Breast Cancer Research,2005,7(5):728-736.
[2]
Scully R, Livingston DM. In search of the tumour-suppressor functions of BRCA1 and BRCA2[J]. Nature, 2000,408(6811):429-432.
[3]
Rakha EA, El-Sayed ME, Green AR.Prognostic markers in triple negative breast cancer[J].Cancer,2007,109(1):25-32.
[4]
Bauer KR,Brown M,Cress RD, et al. Descriptive analysis of estrogen receptor(ER)-negative,progesterone receptor(PR)-negative,and HER2-negative invasive breast cancer,the so-called triple negative phenotype:a population-based study from the California cancer Registry[J]. Cancer,2007,109(9):1721-1728.
[5]
Friedman LS,Ostermeyer EA,Szabo CI,et al.Confirmation of breast and ovarian cancer in ten families[J]. Nature Genetics,1994,8(4):399-404.
